Gem Aromatics Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue Rs 104.0 Cr (+16.2% YoY) with PAT loss Rs 7.0 Cr; EBITDA margin 7.6%. Standalone PAT Rs 8.9 Cr. Dahej capex (~Rs 265 Cr) capitalised; new specialty molecules ramping.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
28 announcements with these filters
Q2FY27 consolidated revenue Rs 104.0 Cr (+16.2% YoY) with PAT loss Rs 7.0 Cr; EBITDA margin 7.6%. Standalone PAT Rs 8.9 Cr. Dahej capex (~Rs 265 Cr) capitalised; new specialty molecules ramping.
Gem Aromatics' Q2FY27 press release shows consolidated revenue of Rs 104 Crore but a Rs 7 Crore consolidated loss. Standalone PAT rose to Rs 8.9 Crore.
Gem Aromatics Ltd reported revenue from operations of ₹104 Cr (+16.2% YoY) and a net loss of ₹7 Cr for Q2 FY27.
Gem Aromatics' board meets on 31 October 2026 to approve September quarter and half-year unaudited results. Trading window closes from 1 October until 48 hours after declaration.
Gem Aromatics Limited announced the resignation of Mr. Kiran Sirsalmath, General Manager – Research & Development. He ceases to be Senior Management Personnel effective September 30, 2026.
Gem Aromatics Limited is acquiring Krystal Ingredients Private Limited for ₹225.21 Crore through the conversion of a loan into equity.
Gem Aromatics Limited approved converting existing inter-company loans into equity shares of its wholly-owned subsidiary, Krystal Ingredients Private Limited, to strengthen the subsidiary's capital base.
The company submitted a revised Annual Report for FY 2025-26, replacing inadvertently attached unfinalized annexures. No content changes were made to the report.
Gem Aromatics Limited held its 29th Annual General Meeting on August 19, 2026, via video conferencing. The meeting transacted various business items, including appointment of directors and remuneration.
Gem Aromatics Ltd reported Q1FY27 financial highlights in a press release. Consolidated revenue reached ₹98.9 Crore, with the company noting seasonally soft performance.
Gem Aromatics reports Q1FY27 standalone revenue growth of 9% YoY. Strategy focuses on scaling the new Dahej facility and expanding into higher-value specialty molecules like cooling agents and phenol derivatives.
Gem Aromatics Ltd reported revenue from operations of ₹98.8 Cr (+12.8% YoY) and a net loss of ₹7.9 Cr for Q1 FY27.
Gem Aromatics Limited has scheduled a board meeting for August 13, 2026. The board will consider and approve unaudited financial results for the quarter ended June 30, 2026.
Gem Aromatics Ltd informs that it dispatched letters to shareholders containing the weblink for accessing the 29th AGM Notice and Annual Report 2025-26.
Gem Aromatics Limited scheduled its 29th Annual General Meeting for August 19, 2026. The agenda includes adopting financial statements and approving director appointments and remunerations.
Gem Aromatics Limited will hold its 29th Annual General Meeting on August 19, 2026. The meeting will address the adoption of financial statements and various leadership appointments.
Gem Aromatics Limited has submitted its Annual Report for the financial year 2025-26. The company also convened its 29th Annual General Meeting for August 19, 2026.
The company filed its quarterly shareholding pattern under Regulation 31(1)(b). This disclosure details the current distribution of equity among promoters and public shareholders.
Promoter Yash Parekh acquired 85,000 equity shares of Gem Aromatics Limited via open market purchase. The transaction, valued at ₹1.27 Crore, increases promoter group skin-in-the-game.
Promoter Mr. Yash Parekh acquired 1,43,760 shares of Gem Aromatics Limited through the open market. This purchase increases the promoter's total equity stake to 9.38%.
Promoter Yash Parekh acquired 1,43,760 equity shares of Gem Aromatics Limited via open market purchase. The transaction, valued at ₹0.22 Crore, increases his stake to 9.38%.
Gem Aromatics reports Q4 FY26 sequential recovery with consolidated revenue of ₹110cr (up 40% QoQ). Strategy focuses on diversifying from mint into high-margin clove derivatives and cooling agents via the new Dahej facility.
Gem Aromatics Ltd reported consolidated revenue of ₹366.5 Crore for FY26. Performance showed sequential improvement, supported by better demand and price realization across key product categories.
Gem Aromatics reports sequential recovery in Q4FY26 with revenue of ₹110 Cr (Consolidated). Focus is on ramp-up at the greenfield Dahej facility and higher-value specialty molecules.
Gem Aromatics appointed Nandan Narula, Dinesh Vasu Thekkepanakkal, and Y. R. Doshi & Associates. These leadership and auditor additions strengthen corporate governance and operational oversight.
Gem Aromatics Ltd reported revenue from operations of ₹110.4 Cr (-45.4% YoY) and net profit of ₹1 Cr (-96.4% YoY) for Q4 FY26.
Gem Aromatics approved its FY26 audited financial results and appointed two additional directors. The board meeting concluded with standalone and consolidated performance reports for investors.
Gem Aromatics Limited scheduled a board meeting for May 21, 2026, to approve audited annual financial results. The trading window remains closed until May 23, 2026.